Skip to content

ABOUT GBC
SOLUTIONS
PRODUCTS
R&D
INNOVATION
INVESTORS
MEDIA
English
- 繁體中文

ABOUT GBC
SOLUTIONS
PRODUCTS
R&D
INNOVATION
INVESTORS
MEDIA
English
- 繁體中文

繁體中文
English

Taiwan GMP Certified.

Post navigation

Previous: GBC enters the laboratory services market.

Next: Diversification

Search

近期文章

GBC July Revenue Reaches NT$24.63 Million, Up 57.82% YoY
GBC Showcases CLIA and AIO Platforms at WHX Bangkok, Expanding Opportunities in Southeast Asia
GBC 2025 EPS Reaches Record High of NT$7.46 as Trading Resumes, Advancing Transformation and Growth
GBC AI Biotech Building Officially Commissioned. Advancing AI Precision Medicine and Expanding Holistic Health Strategy.
GBC’s CellBio™ FX10 Receives 2024 SNQ Symbol of National Quality Certification

近期留言

No comments to show.

彙整

August 2026
July 2026
June 2026
May 2025
January 2025
December 2024
November 2024
April 2024
November 2023
July 2023
August 2022
July 2022
July 2020

分類

Press Releases
未分類

About GBC

Solutions

Products

Our Brands

R & D
- Pharma
- Diagnostic Solution

Innovation

ESG

Investors

Media

Join Us

Contact Us

Documentation

Copyright © 2026 General Biologicals Corporation

Privacy Policy
Terms of Use

Facebook
YouTube
LinkedIn

Inquiry List

Email phone